Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)
Phase 2
Completed
- Conditions
- End-Stage Renal Disease (ESRD)
- Interventions
- Drug: EPN-701 (Oral)
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Epizon Pharma, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05285787
- Locations
- 🇺🇸
Southeastern Clinical Research Institute, LLC, Augusta, Georgia, United States
News
No news found